Amarin Corp Plcuk (AMRN) EBIT Margin Growth (5y) (2018 - 2026)

Amarin Corp Plcuk (AMRN) EBIT Margin Growth (5y) (2018 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2,418.00
Dec 31, 2025 6,649.00
Sep 30, 2025 -1,792.00
Jun 30, 2025 -2,505.00
Mar 31, 2025 -2,437.00
Dec 31, 2024 1,520.00
Sep 30, 2024 -5,548.00
Jun 30, 2024 172.00
Mar 31, 2024 700.00
Dec 31, 2023 10,711.00
Sep 30, 2023 774.00
Jun 30, 2023 3,148.00
Mar 31, 2023 2,969.00
Dec 31, 2022 266.00
Sep 30, 2022 1,212.00
Jun 30, 2022 -4,133.00
Mar 31, 2022 2,366.00
Dec 31, 2021 -7,949.00
Sep 30, 2021 3,786.00
Jun 30, 2021 4,915.00